CN105381466B - A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof - Google Patents

A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof Download PDF

Info

Publication number
CN105381466B
CN105381466B CN201510793864.8A CN201510793864A CN105381466B CN 105381466 B CN105381466 B CN 105381466B CN 201510793864 A CN201510793864 A CN 201510793864A CN 105381466 B CN105381466 B CN 105381466B
Authority
CN
China
Prior art keywords
quantum dot
zns
sio
nano
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510793864.8A
Other languages
Chinese (zh)
Other versions
CN105381466A (en
Inventor
曹健
牛海凤
杨景海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Normal University
Original Assignee
Jilin Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Normal University filed Critical Jilin Normal University
Priority to CN201510793864.8A priority Critical patent/CN105381466B/en
Publication of CN105381466A publication Critical patent/CN105381466A/en
Application granted granted Critical
Publication of CN105381466B publication Critical patent/CN105381466B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides a kind of optomagnetic temperature-sensitive nano combination drug carriers and preparation method thereof, and the invention belongs to pharmaceutical carrier fields.In order to solve the problem of the prior art in terms of preparing optomagnetic temperature-sensitive nano combination drug carrier there are fluorescence, magnetism and Thermo-sensitive is poor and preparation step is unfavorable for industry and generates and propose the preparation method.This method uses N-isopropylacrylamide, ethyl orthosilicate, ZnS:Mn2+Quantum dot and Fe3O4Quantum dot is primary raw material, first with oleic acid to Fe3O4Quantum dot is surface modified;Then by ZnS:Mn2+Quantum dot and Fe3O4Quantum dot is embedded in SiO simultaneously2In;Again with silane coupling agent to SiO2Surface modification double bond;Finally by free radical polymerization coated polymer PNIPAAm, the nano combined pharmaceutical carrier ZnS:Mn of optomagnetic temperature sensitive polymer is realized2+Quantum dot/Fe3O4Quantum dot/SiO2The preparation of/PNIPAAm.

Description

A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof
Technical field
The invention belongs to pharmaceutical carrier fields, and in particular to one kind shines, is magnetic, temperature sensitive compound drug carrier material and Preparation method.
Background technique
It is all Formulations for systemic administration, medicine that common problem, which is oral or injection anticancer drug, in Current cancer therapeutic process Object can also implement drug effect to healthy cell, so that patients immune system further deteriorates not only to cancer cell.Therefore, It is badly in need of the nano combined pharmaceutical carrier of design novel non-toxic, allows drug specificity to aim at cancer cell thin without damaging adjacent healthy To improve the therapeutic efficiency to cancer, and the damage to human body is greatly lowered in born of the same parents.
Temperature sensitive type polymer PNIPAAm (polyisopropyl acrylamide) has good biocompatibility, biodegradable Property and temperature switch characteristic, preparation method are simple, and stability is good.In recent years, using PNIPAAm and with light, magnetic property Inorganic composite materials construct nano combined pharmaceutical carrier and have obtained the extensive concern of people, can realize it in vivo using photoluminescent property Imaging and drug tracking, are oriented to tumor tissues for pharmaceutical carrier using magnetic orientation technology, realize medicine using the Thermo-sensitive of polymer The controlled release of object.Although by PNIPAAm and inorganic nano material it is compound be very promising medical carrier, system Standby process also needs to overcome many problems.There are two main problems, and one is that magnetic substance asks the fluorescent quenching of fluorescent material Topic, one be inorganic material Yu polymer P NIPAAm connectivity problem.Directly affect the magnetism, fluorescence and temperature of product Sensibility.Furthermore existing preparation method step is difficult to control, and prepared compound property is inhomogenous, is not easy to realize industry Change.
Summary of the invention
In order to solve the above difficulties, optomagnetic temperature-sensitive nano combination drug carrier provided by the present invention, with ZnS:Mn2+Quantum Point is used as fluorescence source, with Fe3O4Quantum dot after surface modification, is respectively coated by SiO as magnetic source and with oleic acid2, reuse silane Coupling agent is to SiO2It is surface modified, finally coats polyisopropyl acrylamide again, form ZnS:Mn2+Quantum dot/Fe3O4Amount Sub- point/SiO2/ polyisopropyl acrylamide structure.
The optomagnetic temperature-sensitive nano combination drug carrier the preparation method is as follows:
One, by 300~600mg Fe3O4Quantum dot is scattered in 5~20ml water, and the oleic acid of water volume 15~50% is added, 1~6h is reacted under the conditions of 20~60 DEG C, obtains the Fe of oleic acid modified3O4Quantum dot.
Two, by the Fe after oleic acid modified3O4Quantum dot washing, drying are scattered in hexamethylene after pulverizing, and are obtained Fe3O4Quantum dot ring hexane solution.
Three, by ZnS:Mn2+Quantum dot is scattered in hexamethylene, obtains ZnS:Mn2+Quantum dot ring hexane solution.
Four, by polyoxyethylenes (5) nonylplenyl ether, branching (Igepal CO-520) is scattered in hexamethylene, Igepal The ratio between additional amount of CO-520 and hexamethylene is 0.06~0.07:1, and ZnS:Mn is added2+The cyclohexane solution and Fe of quantum dot3O4 Quantum dot ring hexane solution is dispersed to uniformly, addition ammonium hydroxide adjusting pH to alkalinity, and addition hexamethylene total volume 0.15%~ 0.8% ethyl orthosilicate (TEOS) reacts 10~40h, obtains ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2It is nano combined Object is washed after reaction, is dried;Wherein, the ZnS:Mn being added2+Quantum dot ring hexane solution and Fe3O4Amount ZnS:Mn in son point cyclohexane solution2+Quantum dot and Fe3O4The mass ratio of quantum dot is between 3:1~6:1.
Five, by ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2The hydrochloric acid that nano-complex is dispersed in pH=3~5 is water-soluble In liquid, 75~85 DEG C of 1~2h of heating obtain the ZnS:Mn of surface hydroxylation2+Quantum dot/Fe3O4Quantum dot/SiO2It is nano combined Object.
Six, the alcohol-water mixed solution (volume ratio of alcohol to water is 3~5:1) for configuring pH=3~5.5, is added silane coupling agent The ZnS:Mn of surface hydroxylation is added after silane coupling agent KH570 hydrolysis in KH5702+Quantum dot/Fe3O4Quantum dot/SiO2It receives Rice compound is surface modified it, and 6~7h is reacted under the conditions of 70~85 DEG C.The wherein addition of silane coupling agent KH570 Amount is the 0.25%~0.5% of alcohol-water mixed solution total volume.
Seven, silane coupling agent is modified into ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex is dispersed in water, Monomer n-isopropyl acrylamide (NIPAAm), acrylamide (AAm) and N-N- methylene-bisacrylamide (BIS) is added, removes At 70~80 DEG C after oxygen in dereaction system, the initiator for reaction time is added to obtain ZnS:Mn after 4~6h2+Quantum dot/ Fe3O4Quantum dot/SiO2/ PNIPAAm nano-complex.Wherein, quality is than n-isopropyl acrylamide (NIPAAm): acryloyl Amine (AAm): N,N methylene bis acrylamide (BIS): silane coupling agent modifies ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2 Nano-complex=4.5~5.5:0.3~0.35:0.4~0.6:1.The initiator is potassium peroxydisulfate (KPS).
Eight, pure ZnS:Mn is obtained after washed, dry2+Quantum dot/Fe3O4Quantum dot/SiO2/ poly- isopropyl propylene Amide nano-complex.
In step 6, it is two sections of progress that 6~7h is reacted under the conditions of 70~85 DEG C: first reacting 5h under the conditions of 70 DEG C, so Temperature is increased to 80~85 DEG C afterwards, the reaction was continued, and 1~2h can obtain better effect.
The invention has the advantages that:
1. the present invention uses the method for reverse micro emulsion by ZnS:Mn2+Quantum dot and Fe3O4Quantum dot is coated on SiO simultaneously2 In, it is prepared for having both fluorescence and magnetic silicon ball.Of uniform size, size is controllable, good dispersion.
2. the method for the present invention has carried out surface modification to silicon ball by KH570 silane coupling agent, it is double to substantially increase surface The grafting rate of key, and then significantly improve grafting rate of the polymer in silicon ball.
3. the present invention uses traditional radical polymerization, there is fluorescence and magnetic titanium dioxide in addition at the beginning of preparation process Silicon ball, a step are obtained with fluorescence, magnetism and thermally sensitive polymer based nanocomposites, and method is simple, can weigh Renaturation is good, can control SiO by adjusting TEOS additional amount2The thickness of clad, passes through ZnS:Mn2+Quantum dot and Fe3O4Quantum The additional proportion adjustment of point can control its fluorescence and magnetic intensity.
4. the present invention is not only easy to operate, step is clear, has environmentally friendly, economic, convenient, simple operation and other advantages, is easy to Realize large-scale production, while this method preparation polymer nanocomposites even size distribution, have both fluorescence, magnetism and Temperature sensitivity can be used as medical carrier.
5, target product of the invention fluorescence efficiency with higher, stronger superparamagnetism and be higher than human body temperature Temperature-sensitive, accommodate very much as bio-pharmaceutical carrier.
Detailed description of the invention
Fig. 1 target product transmission electron microscope photo of the present invention;
Fig. 2 target product light transmittance of the present invention varies with temperature curve graph;
Fig. 3 target product fluorescence emission spectrum of the present invention;
Fig. 4 a target product aqueous dispersion photo of the present invention;
Fig. 4 b target product ultraviolet excitation photo of the present invention;
Fig. 5 hysteresis loop of the present invention (in figure, M is the sample intensity of magnetization, and H is magnetic field strength);
Target product assembles photo under Fig. 6 external magnetic field.
Specific embodiment
Technical solution of the present invention is further explained and is illustrated in a manner of specific embodiment below.Following embodiment is not Specified otherwise carries out at normal temperatures and pressures.
Reagent used in the embodiment of the present invention is as follows:
Zinc acetate (Zn (CH3COO)2·2H2O, Shenyang Sinopharm Chemical Reagent Co., Ltd. analyze pure);
Manganese acetate (Mn (CH3COO)2·4H2O, Aladdin reagent are analyzed pure);
Oleic acid (C18H34O, Shenyang Sinopharm Chemical Reagent Co., Ltd. analyze pure);
Enuatrol (C18H33NaO2, Shenyang Sinopharm Chemical Reagent Co., Ltd., chemistry it is pure);
Ethyl alcohol (C2H6O, Shenyang Sinopharm Chemical Reagent Co., Ltd.) it is that analysis is pure;
Sodium Sulphate Nine Hydroxide (Na2S·9H2O, Shenyang Sinopharm Chemical Reagent Co., Ltd. analyze pure);
Ferric trichloride (FeCl3·6H2O, Shenyang Sinopharm Chemical Reagent Co., Ltd. analyze pure);
Frerrous chloride (FeCl2·4H2O, Shenyang Sinopharm Chemical Reagent Co., Ltd. analyze pure);
Ammonium hydroxide (NH3·H2O, Beijing Chemical Plant analyze pure);
Macrogol 4000 (PEG 4000) (H (OGH2CH2)nOH, Shenyang Sinopharm Chemical Reagent Co., Ltd., analysis It is pure);
Ethyl orthosilicate (TEOS) (C8H20O4Si, Shenyang Sinopharm Chemical Reagent Co., Ltd. analyze pure);
Hexamethylene (C6H12, Shenyang Sinopharm Chemical Reagent Co., Ltd. analyzes pure);
γ-(methacryloxypropyl) propyl trimethoxy silicane (silane coupling agent KH570, CH2=C (CH3)COOC3H6Si (OCH3)3, Sigma-Aldrich, biological reagent);
N-isopropyl acrylamide (NIPAAm) (C6H11NO, Aladdin reagent are analyzed pure);
Acrylamide (AAm) (C3H5NO, Aladdin reagent, excellent pure grade);
Potassium peroxydisulfate (KPS) (K2S2O8, Aladdin reagent, Metal Substrate (metals basis));
N-N- methylene-bisacrylamide (BIS) (C7H10N2O2, Aladdin reagent, electronic grade reagents);
Polyoxyethylenes (5) nonylplenyl ether, branching (Igepal CO-520) (C2H4O)n·C15H24O, n~5, I Fourth reagent).
Embodiment 1
(1) solvent hot preparation zinc sulphide mixes manganese quantum dot: weighing 0.8561g Zn (CH3COO)2·2H2O and 0.0097g Mn(CH3COO)2·4H2O is poured into the 250ml beaker equipped with 7ml deionized water, magnetic agitation 10min to dissolution.So It states addition 9.75ml oleic acid, 1.3g enuatrol, 16ml ethyl alcohol in solution, and magnetic agitation 1h upwards in turn afterwards, forms latex A. By 0.937g Na2S·9H2O is poured into the 250ml beaker equipped with 7ml deionized water, and magnetic agitation 10min obtains sulphur to dissolving Change sodium water solution.Sodium sulfide solution is added in latex A, and magnetic agitation 2h obtains solution B, and B solution is transferred to The temperature that in the reaction kettle of 50ml, reaction kettle is put into drying box, and drying box is arranged is 190 DEG C, reacts 12h.It reacts The product ethyl alcohol arrived: hexamethylene=1:1 solution centrifuge washing is three times.60 DEG C of dry 5h obtain ZnS:Mn2+Quantum dot.
(2) co-precipitation prepares ferroso-ferric oxide quantum dot: weighing 2.703g FeCl3·6H2O、1.192g FeCl2· 4H2O and 10g PEG 4000 is added in the 500ml three-neck flask for filling 150ml deionized water, mechanical stirring to dissolution.It will Solution temperature is warming up to 90 DEG C, and 100ml NH is added3·H2O stirs 2h.Products therefrom is centrifuged, with ethyl alcohol and deionization moisture It Xi Di not be 3 times.In aqueous solution by sample dispersion, Fe is obtained3O4Quantum dot aqueous solution.
(3) oleic acid modified ferroso-ferric oxide quantum dot: the Fe that will be prepared in 300mg step (2)3O4Quantum dot, ultrasound 20min is dispersed in the 100ml conical flask for filling 20ml deionized water, and 5ml oleic acid is then added into conical flask, continues ultrasound It is placed it in shaking table after 30min, shaking table temperature 60 C, revolving speed 100rpm, reaction time 6h is set.After the reaction was completed, sharp It removes extra oleic acid three times with ethanol washing, is then dried in vacuo 12h at 60 DEG C, pulverize stand-by, obtain oleic acid and repair The Fe of decorations3O4Quantum dot.By 10mg Fe3O4Quantum dot is dispersed in 10ml hexamethylene, is made into the Fe that concentration is 1mg/ml3O4Amount Son point cyclohexane solution.
(4) coated silica: measuring 3.7ml Igepal CO-520, by its ultrasonic disperse in the hexamethylene of 60ml, Then by 2ml ZnS:Mn2+The cyclohexane solution (5mg/ml) and 2ml Fe of QDs3O4Cyclohexane solution (1mg/ml) simultaneously plus Enter into above-mentioned solution, stirring 30min makes it be uniformly dispersed, after 0.5ml ammonium hydroxide (25%) is rapidly joined, stir after 1h to body 250 μ l TEOS are added in system, room temperature reaction 15-20h obtains ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano combined material Material.Final product ethyl alcohol, deionized water are washed for several times, then save product dispersion in ethanol or 60 DEG C of dry 6h are obtained To grey-brown powder, ZnS:Mn is obtained2+Quantum dot/Fe3O4Quantum dot/SiO2Nanocomposite.
(5) silane coupling agent surface modification: 30mg ZnS:Mn is weighed2+Quantum dot/Fe3O4Quantum dot/SiO2It is nano combined Material is dispersed in the aqueous hydrochloric acid solution of 40ml PH=4, and ultrasonic 20min makes it be uniformly dispersed, and then dispersion liquid is added 85 DEG C of heating 1-2h in the three-neck flask of 250ml obtain the ZnS:Mn of surface hydroxylation after 10000rpm is centrifuged 5min2+Quantum Point/Fe3O4Quantum dot/SiO2Nanocomposite.2. measuring the mixed solution (ethyl alcohol: water=4:1) of 40ml PH=4, it is added 0.2ml KH570 is placed in stirring hydrolysis 2h on magnetic stirring apparatus.The ZnS:Mn of surface hydroxylation is added2+Quantum dot/Fe3O4Amount Sub- point/SiO2Solution is added in the three-neck flask of 250ml after ultrasonic disperse 30min, by three-neck flask by nanocomposite It is placed in water-bath, 5h is stirred at 70 DEG C, water bath temperature is then increased to 80-85 DEG C, continue to stir 1-2h.To solution It is centrifuged, using ethanol washing 6 times, centrifugation products therefrom, which is dispersed in ethanol solution, to be saved, and obtains what the surface KH570 was modified ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Ethanol solution.
(6) surface grafting polymerization object: by the ZnS:Mn of the KH570 modification of step (5) synthesis2+Quantum dot/Fe3O4Quantum Point/SiO2Nanocomposite is washed with deionized three times, and is dispersed in ultrasound 20min in 100ml deionized water, then will It is added in the four-neck flask of 250ml, is placed in water-bath, thereto be added 0.150g NIPAAm, 9.4mg AAm and The BIS of 0.015g is stirred at 200 rpm with mechanical stirring stick, and logical nitrogen deoxygenates 0.5h.Then water-bath is warming up to 70 DEG C, it is added KPS 1.5ml (4mg/ml), reaction time 4h.It is centrifuged and benefit is washed with deionized three times, be subsequently placed in vacuum Drying obtains target product ZnS:Mn for 24 hours in freeze drier2+Quantum dot/Fe3O4Quantum dot/SiO2/PNIPAAm。
Embodiment 2
Embodiment 1 be preferred embodiment of the present invention, in addition to the method and step that embodiment 1 is described, by the additional amount of raw material with Reaction condition run business into particular one micromodification change, analyzed referring to existing method and according to reaction principle, disclosed in summary of the invention of the invention Reaction condition changes the material alterations that will not cause the method for the present invention, and the present invention may be implemented.Such as: the embodiment of the present invention In 1 when modifying using oleic acid ferroso-ferric oxide surface, the oleic acid of deionized water volume 15%~50% is added, instead At once it is reacted 1~6 hour at 20~60 DEG C.The specific steps of coated silica can refer to the prior art, further hydroxyl The hydroxyl of surface silica dioxide can be realized in 75~85 DEG C of 1~2h of heating under conditions of pH=3~5 when baseization processing Change.The additional amount of KH570 is 0.1~0.2mL/40mL alcohol solution when heating modifies surface using silane coupling agent, And it needs to carry out under conditions of PH=3~5.5.Present invention ZnS:Mn during the preparation process2+Quantum dot and Fe3O4Quantum dot Mass ratio can preferably ensure magnetic and fluorescence effect in 3:1~6:1.It is added surfactant Igepal CO-520's It uses and is controlled and extraordinary effect is coated with for silica between 0.06~0.07:1, improve the present invention Technical effect.
Embodiment 3
Structure and function characterize
The present invention respectively characterizes target product from structure and function, to target product in a manner of transmission electron microscope Structure is characterized, as shown in Figure 1, black region is ZnS:Mn2+Quantum dot or Fe3O4Quantum dot, surface Dark grey area Domain is surface coated SiO2, outermost layer light gray areas is PNIPAAm.
Functional characterization of the invention is divided into temperature-sensing property characterization, magnetic characterization and characteristics of luminescence characterization.
The present invention varies with temperature curve by light transmittance and characterizes to its temperature-sensing property.As shown in Fig. 2, target product Phase transition temperature be 41.1 DEG C, greater than 37 DEG C of body temperature of human body, therefore the temperature of control vector can be passed through and realize drug Controlled release.
Fig. 3 is target product ZnS:Mn of the present invention2+Quantum dot/Fe3O4Quantum dot/SiO2The fluorescence emission of/PNIPAAm Spectrum, from figure 3, it can be seen that the luminous peak position of target product is in 592.7nm.The present invention is under the conditions of 365nm ultraviolet excitation The target sample aqueous solution of brown issues glassy yellow fluorescence (as shown in figures 4 a and 4b).Illustrate target product ZnS:Mn2+Quantum Point/Fe3O4Quantum dot/SiO2/ PNIPAAm can be used as fluorescent marker application in vivo.
By Fig. 5, it can be seen that, target product of the present invention has superparamagnetism.Targeting experiment is carried out to solution using magnet Target product ZnS:Mn is assembled in (as shown in Figure 6), discovery solution side2+Quantum dot/Fe3O4Quantum dot/SiO2/ PNIPAAm, Solution colour becomes milky by brown, illustrates target product ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2/ PNIPAAm can To realize that targeting is mobile under the action of external magnetic field, the positioning release of drug is realized.

Claims (6)

1. a kind of optomagnetic temperature-sensitive nano combination drug carrier, it is characterised in that: be coated with SiO on surface2ZnS:Mn2+Quantum dot SiO is coated with surface2Fe3O4The external sheath of quantum dot has polyisopropyl acrylamide, constitutes nano-complex;It is described Fe3O4Oleic acid surface modification is passed through on the surface of quantum dot, and preparation step is specific as follows:
One, by Fe3O4Quantum dot is dispersed in water, Fe3O4The mass volume ratio of quantum dot and water is 15 ~ 120 mg/ml, and water is added The oleic acid of volume 15% ~ 50% reacts 1 ~ 6h under the conditions of 20 ~ 60 DEG C, obtains the Fe of oleic acid modified3O4Quantum dot;
Two, by the Fe after oleic acid modified3O4Quantum dot washing, drying are scattered in hexamethylene after pulverizing, and obtain Fe3O4Amount Son point cyclohexane solution;
Three, by ZnS:Mn2+Quantum dot is scattered in hexamethylene, obtains ZnS:Mn2+Quantum dot ring hexane solution;
Four, by polyoxyethylenes (5) nonylplenyl ether, branching is scattered in hexamethylene, polyoxyethylenes (5) nonylplenyl ether, The additional amount volume ratio of branching and hexamethylene is 0.06 ~ 0.07:1, and ZnS:Mn is added2+The cyclohexane solution and Fe of quantum dot3O4 Quantum dot ring hexane solution is dispersed to uniformly, and ammonium hydroxide is added and adjusts pH to alkalinity, hexamethylene total volume 0.15% ~ 0.8% is added Ethyl orthosilicate reacts 10 ~ 40h, obtains ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex, after reaction It washed, be dried;Wherein, the ZnS:Mn being added2+Quantum dot ring hexane solution and Fe3O4Quantum dot ring hexane solution Middle ZnS:Mn2+Quantum dot and Fe3O4The mass ratio of quantum dot is between 3:1 ~ 6:1;
Five, by ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex is dispersed in the aqueous hydrochloric acid solution of pH=3 ~ 5, and 75 ~ 85 DEG C of 1 ~ 2h of heating, obtain the ZnS:Mn of surface hydroxylation2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex;
Six, the alcohol-water mixed solution of pH=3 ~ 5.5 is configured, silane coupling agent KH570 is added, to silane coupling agent KH570 water The ZnS:Mn of surface hydroxylation is added in Xie Hou2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex is surface modified it, 6 ~ 7h is reacted under the conditions of 70 ~ 85 DEG C;Wherein, the additional amount of silane coupling agent KH570 is alcohol-water mixed solution total volume 0.25%~0.5%;The volume ratio of second alcohol and water is 3 ~ 5:1 in the alcohol-water mixed solution;
Seven, silane coupling agent is modified into ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex is dispersed in water, and is added Monomer n-isopropyl acrylamide, acrylamide and N-N- methylene-bisacrylamide, remove in reaction system after oxygen 70 ~ 80 DEG C, the initiator for reaction time is added to obtain ZnS:Mn after 4 ~ 6h2+Quantum dot/Fe3O4Quantum dot/SiO2/ poly- isopropyl third Acrylamide nano-complex;Wherein, n-isopropyl acrylamide in mass ratio: acrylamide: N, N- methylene bisacrylamide acyl Amine: silane coupling agent modifies ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex=4.5 ~ 5.5:0.3 ~ 0.35: 0.4~0.6:1。
2. a kind of preparation method of optomagnetic temperature-sensitive nano combination drug carrier described in claim 1, the specific steps are as follows:
One, by Fe3O4Quantum dot is dispersed in water, Fe3O4The mass volume ratio of quantum dot and water is 15 ~ 120 mg/ml, and water is added The oleic acid of volume 15% ~ 50% reacts 1 ~ 6h under the conditions of 20 ~ 60 DEG C, obtains the Fe of oleic acid modified3O4Quantum dot;
Two, by the Fe after oleic acid modified3O4Quantum dot washing, drying are scattered in hexamethylene after pulverizing, and obtain Fe3O4Amount Son point cyclohexane solution;
Three, by ZnS:Mn2+Quantum dot is scattered in hexamethylene, obtains ZnS:Mn2+Quantum dot ring hexane solution;
Four, by polyoxyethylenes (5) nonylplenyl ether, branching is scattered in hexamethylene, polyoxyethylenes (5) nonylplenyl ether, The additional amount volume ratio of branching and hexamethylene is 0.06 ~ 0.07:1, and ZnS:Mn is added2+The cyclohexane solution and Fe of quantum dot3O4 Quantum dot ring hexane solution is dispersed to uniformly, and ammonium hydroxide is added and adjusts pH to alkalinity, hexamethylene total volume 0.15% ~ 0.8% is added Ethyl orthosilicate reacts 10 ~ 40h, obtains ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex, after reaction It washed, be dried;Wherein, the ZnS:Mn being added2+Quantum dot ring hexane solution and Fe3O4Quantum dot ring hexane solution Middle ZnS:Mn2+Quantum dot and Fe3O4The mass ratio of quantum dot is between 3:1 ~ 6:1;
Five, by ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex is dispersed in the aqueous hydrochloric acid solution of pH=3 ~ 5, and 75 ~ 85 DEG C of 1 ~ 2h of heating, obtain the ZnS:Mn of surface hydroxylation2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex;
Six, the alcohol-water mixed solution of pH=3 ~ 5.5 is configured, silane coupling agent KH570 is added, to silane coupling agent KH570 water The ZnS:Mn of surface hydroxylation is added in Xie Hou2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex is surface modified it, 6 ~ 7h is reacted under the conditions of 70 ~ 85 DEG C;Wherein, the additional amount of silane coupling agent KH570 is alcohol-water mixed solution total volume 0.25%~0.5%;The volume ratio of second alcohol and water is 3 ~ 5:1 in the alcohol-water mixed solution;
Seven, silane coupling agent is modified into ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex is dispersed in water, and is added Monomer n-isopropyl acrylamide, acrylamide and N-N- methylene-bisacrylamide, remove in reaction system after oxygen 70 ~ 80 DEG C, the initiator for reaction time is added to obtain ZnS:Mn after 4 ~ 6h2+Quantum dot/Fe3O4Quantum dot/SiO2/ poly- isopropyl third Acrylamide nano-complex;Wherein, n-isopropyl acrylamide in mass ratio: acrylamide: N, N- methylene bisacrylamide acyl Amine: silane coupling agent modifies ZnS:Mn2+Quantum dot/Fe3O4Quantum dot/SiO2Nano-complex=4.5 ~ 5.5:0.3 ~ 0.35: 0.4~0.6:1。
3. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, it is characterised in that: step 7 Pure ZnS:Mn is obtained after washing, drying after the completion2+Quantum dot/Fe3O4Quantum dot/SiO2/ polyisopropyl acrylamide Nano-complex.
4. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, it is characterised in that: described to draw Hair agent is potassium peroxydisulfate.
5. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, it is characterised in that: step 6 In, it is two sections of progress that 6 ~ 7h is reacted under the conditions of 70 ~ 85 DEG C: first under the conditions of 70 DEG C 5h is reacted, temperature is then increased to 80 ~ 85 DEG C, the reaction was continued 1 ~ 2h.
6. the preparation method of optomagnetic temperature-sensitive nano combination drug carrier according to claim 2, it is characterised in that: step 7 Middle n-isopropyl acrylamide: acrylamide: N,N methylene bis acrylamide: silane coupling agent modifies ZnS:Mn2+Quantum Point/Fe3O4Quantum dot/SiO2Nano-complex=5:0.31:0.5:1.
CN201510793864.8A 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof Expired - Fee Related CN105381466B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510793864.8A CN105381466B (en) 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510793864.8A CN105381466B (en) 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105381466A CN105381466A (en) 2016-03-09
CN105381466B true CN105381466B (en) 2019-04-09

Family

ID=55414636

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510793864.8A Expired - Fee Related CN105381466B (en) 2015-11-18 2015-11-18 A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105381466B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109277079A (en) * 2018-12-01 2019-01-29 浙江海洋大学 A kind of preparation method of the composite material of light sensitivity
CN109277091A (en) * 2018-12-01 2019-01-29 浙江海洋大学 A kind of preparation method of the composite material of Thermo-sensitive
CN110129025A (en) * 2019-05-14 2019-08-16 上海大学 The preparation method of simple Silica-coated quantum dot
CN115159587A (en) * 2022-07-21 2022-10-11 江苏先丰纳米材料科技有限公司 Preparation method of molybdenum trioxide nanosheet loaded ferroferric oxide magnetic nanoparticle

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675565A (en) * 2012-05-09 2012-09-19 天津大学 Carbon quantum dot-poly N-isopropylacrylamide composite material and preparation method thereof
CN103204972A (en) * 2013-04-23 2013-07-17 上海师范大学 Thermo-sensitive fluorescent carbon nano composite material and preparation method thereof
CN103239410A (en) * 2013-05-02 2013-08-14 上海交通大学 Preparation method of fluorescence and heat/pH sensitive organic-inorganic composite microsphere carrier
CN103386135A (en) * 2013-07-24 2013-11-13 上海交通大学 Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675565A (en) * 2012-05-09 2012-09-19 天津大学 Carbon quantum dot-poly N-isopropylacrylamide composite material and preparation method thereof
CN103204972A (en) * 2013-04-23 2013-07-17 上海师范大学 Thermo-sensitive fluorescent carbon nano composite material and preparation method thereof
CN103239410A (en) * 2013-05-02 2013-08-14 上海交通大学 Preparation method of fluorescence and heat/pH sensitive organic-inorganic composite microsphere carrier
CN103386135A (en) * 2013-07-24 2013-11-13 上海交通大学 Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Effects of surface modification and SiO2 thickness on the optical and superparamagnetic properties of the water-soluble ZnS:Mn2+ nanowires/Fe3O4 quantum dots/SiO2 heterostructures;Jian Cao等;《CrystEngComm》;20130704;第15卷(第35期);第6971-6978页
Functional and Multifunctional Nanoparticles for Bioimaging and Biosensing;Subramanian Tamil Selvan等;《Langmuir》;20091204;第26卷(第14期);第11631–11641页
Multifunctional PNIPAM/Fe3O4–ZnS hybrid hollow spheres: Synthesis, characterization, and properties;Ge Liu等;《Journal of Colloid and Interface Science》;20130208;第397卷;第73-79页

Also Published As

Publication number Publication date
CN105381466A (en) 2016-03-09

Similar Documents

Publication Publication Date Title
CN105381466B (en) A kind of optomagnetic temperature-sensitive nano combination drug carrier and preparation method thereof
CN104745192B (en) A kind of magnetic fluorescent dual-function nanoparticle probe and preparation method thereof
Zhang et al. Multifunctional superparamagnetic iron oxide nanoparticles: design, synthesis and biomedical photonic applications
Ladj et al. Polymer encapsulation of inorganic nanoparticles for biomedical applications
Sounderya et al. Use of core/shell structured nanoparticles for biomedical applications
CN102051177B (en) Water-soluble fluorescent magnetic nano particles and preparation method thereof
Sobczak-Kupiec et al. Magnetic nanomaterials and sensors for biological detection
Gan et al. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica
CN104762085B (en) A kind of magnetic fluorescence composite Nano bioprobe and preparation method thereof
CN100558824C (en) Magnetic/metal/fluorescence composite silicon dioxide nano particle and preparation method thereof
CN102120168B (en) Multifunctional core-shell structure fluorescent coding magnetic microspheres and preparation method thereof
CN107921181A (en) Application of the magnetic material in calculus taking-up
Xu et al. High purity microfluidic sorting and in situ inactivation of circulating tumor cells based on multifunctional magnetic composites
CN105936820B (en) A kind of water-soluble biological compatibility fluorescence magnetic nanocluster and preparation method thereof
Esfandyari et al. Capture and detection of rare cancer cells in blood by intrinsic fluorescence of a novel functionalized diatom
Cui et al. Rapid and efficient isolation and detection of circulating tumor cells based on ZnS: Mn2+ quantum dots and magnetic nanocomposites
Xiong et al. Remote and real time control of an FVIO–enzyme hybrid nanocatalyst using magnetic stimulation
Zhao et al. Multifunctional superparamagnetic Fe3O4@ SiO2 core/shell nanoparticles: design and application for cell imaging
Dembski et al. Core-shell nanoparticles and their use for in vitro and in vivo diagnostics
CN102234507A (en) Preparation of fluorescent silicon dioxide nanospheres
CN104237503A (en) Mitochondria targeted fluorescent labeling magnetic nano material as well as preparation method and application of mitochondria targeted fluorescent labeling magnetic nano material
CN108567983B (en) Nano composite material, preparation method and application thereof
Liu et al. A facile fabrication of spherical and beanpod-like magnetic-fluorescent particles with targeting functionalities
Wang et al. Preparation of hybrid fluorescent–magnetic nanoparticles for application to cellular imaging by self-assembly
Ma et al. A microemulsion preparation of nanoparticles of europium in silica with luminescence enhancement using silver

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190409

Termination date: 20191118

CF01 Termination of patent right due to non-payment of annual fee